Finanças

Notícias Discussões Sinais técnicos Previsão Sazonais

EBITDA de Phibro Animal Health Corporation.

Dados anuais

2012

2013

2014

2015

2016

2017

2018

2019

2020

2021

2022

2023

2024

TTM

‪0,00‬

‪‪35,00 M‬‬

‪‪70,00 M‬‬

‪‪105,00 M‬‬

‪‪140,00 M‬‬

Período

Valor

Variação

Variação %

TTM

‪‪132,43 M‬‬

+‪‪33,83 M‬‬

+‪34,31‬%

2024

‪‪98,60 M‬‬

‪‪−15,39 M‬‬

‪−13,50‬%

2023

‪‪113,99 M‬‬

+‪‪1,78 M‬‬

+‪1,59‬%

2022

‪‪112,21 M‬‬

+‪‪4,36 M‬‬

+‪4,04‬%

2021

‪‪107,85 M‬‬

+‪‪2,21 M‬‬

+‪2,09‬%

2020

‪‪105,64 M‬‬

‪‪−9,07 M‬‬

‪−7,91‬%

2019

2018

2017

2016

2015

2014

2013

2012

Dados trimestrais

Q4 '17

Q1 '18

Q2 '18

Q3 '18

Q4 '18

Q1 '19

Q2 '19

Q3 '19

Q4 '19

Q1 '20

Q2 '20

Q3 '20

Q4 '20

Q1 '21

Q2 '21

Q3 '21

Q4 '21

Q1 '22

Q2 '22

Q3 '22

Q4 '22

Q1 '23

Q2 '23

Q3 '23

Q4 '23

Q1 '24

Q2 '24

Q3 '24

Q4 '24

Q1 '25

Q2 '25

‪0,00‬

‪‪13,00 M‬‬

‪‪26,00 M‬‬

‪‪39,00 M‬‬

‪‪52,00 M‬‬

Período

Valor

Variação

Variação %

Q2 '25

‪‪49,32 M‬‬

+‪‪17,45 M‬‬

+‪54,72‬%

Q1 '25

‪‪31,88 M‬‬

+‪‪10,04 M‬‬

+‪45,97‬%

Q4 '24

‪‪21,84 M‬‬

‪‪−7,55 M‬‬

‪−25,68‬%

Q3 '24

‪‪29,39 M‬‬

+‪‪404,00 K‬‬

+‪1,39‬%

Q2 '24

‪‪28,98 M‬‬

+‪‪10,59 M‬‬

+‪57,61‬%

Q1 '24

‪‪18,39 M‬‬

‪‪−14,03 M‬‬

‪−43,27‬%

Q4 '23

‪‪32,42 M‬‬

+‪‪4,68 M‬‬

+‪16,88‬%

Q3 '23

‪‪27,73 M‬‬

‪‪−3,53 M‬‬

‪−11,30‬%

Q2 '23

Q1 '23

Q4 '22

Q3 '22

Q2 '22

Q1 '22

Q4 '21

Q3 '21

Q2 '21

Q1 '21

Q4 '20

Q3 '20

Q2 '20

Q1 '20

Q4 '19

Q3 '19

Q2 '19

Q1 '19

Q4 '18

Q3 '18

Q2 '18

Q1 '18

Q4 '17